The Gauhati Medical College and Hospital (GMCH) has been selected for the second phase clinical testing of India's indigenously developed coronavirus vaccine, Covaxin, Assam Health Minister Himanta Biswa Sarma said.
He said the GMCH would provide all-out support for the second phase clinical testing of Covaxin, which has already shown successful results in phase-one clinical trials.
According to the Minister, till yesterday night, Assam has tested more than 18.22 lakh samples with 79,667 people testing positive for Covid-19. Of the total cases, 56,734 people have recovered from the disease with the recovery rate being 71.2 per cent and mortality rate 0.25 per cent.
Sarma said 197 people have died due to Covid-19 in the state so far. In terms of recovery rate, he said, five states — Delhi, Tamil Nadu, Gujarat, West Bengal and Tripura — were better than Assam..
The Government of Myanmar has expressed deep gratitude for India's swift and substantial support in…
Protesters affected by the Diamer-Bhasha Dam project offered Eid-ul-Fitr prayers at their ongoing protest camp…
External Affairs Minister S. Jaishankar recognised the screening of 'The Diplomat' in Israel for a…
By Rajnish Singh Operation Brahma by India is operating at full tilt aimed towards providing…
Indian Naval Ship (INS) Tarkash successfully intercepted and seized over 2500 kg of narcotics in…
The Rajasthan Samagra Kalyan Sansthan (RSKS India) made a significant impact during the 58th session…
